377 related articles for article (PubMed ID: 28571695)
1. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
[TBL] [Abstract][Full Text] [Related]
2. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
3. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
Hussain AI; Cordeiro M; Sevilla E; Liu J
Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
[TBL] [Abstract][Full Text] [Related]
4. Avian Cell Line DuckCelt
Chupin C; Pizzorno A; Traversier A; Brun P; Ogonczyk-Makowska D; Padey B; Milesi C; Dulière V; Laurent E; Julien T; Galloux M; Lina B; Eléouët JF; Moreau K; Hamelin ME; Terrier O; Boivin G; Dubois J; Rosa-Calatrava M
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696298
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.
Lohr V; Genzel Y; Jordan I; Katinger D; Mahr S; Sandig V; Reichl U
BMC Biotechnol; 2012 Oct; 12():79. PubMed ID: 23110398
[TBL] [Abstract][Full Text] [Related]
6. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
[TBL] [Abstract][Full Text] [Related]
7. Experimental studies from shake flasks to 3 L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt®-T17.
Tingaud V; Bordes C; Al Mouazen E; Cogné C; Bolzinger MA; Lawton P
J Biol Eng; 2023 Apr; 17(1):31. PubMed ID: 37095522
[TBL] [Abstract][Full Text] [Related]
8. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
9. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
Tapia F; Wohlfarth D; Sandig V; Jordan I; Genzel Y; Reichl U
PLoS One; 2019; 14(11):e0224317. PubMed ID: 31689309
[TBL] [Abstract][Full Text] [Related]
10. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
11. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
12. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
[TBL] [Abstract][Full Text] [Related]
13. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
14. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan.
Li YT; Ko HY; Lee CC; Lai CY; Kao CL; Yang C; Wang WB; King CC
PLoS One; 2015; 10(8):e0133910. PubMed ID: 26263554
[TBL] [Abstract][Full Text] [Related]
16. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
[TBL] [Abstract][Full Text] [Related]
17. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Donis RO; ; Davis CT; Foust A; Hossain MJ; Johnson A; Klimov A; Loughlin R; Xu X; Tsai T; Blayer S; Trusheim H; Colegate T; Fox J; Taylor B; Hussain A; Barr I; Baas C; Louwerens J; Geuns E; Lee MS; Venhuizen O; Neumeier E; Ziegler T
Vaccine; 2014 Nov; 32(48):6583-90. PubMed ID: 24975811
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells.
Frensing T; Kupke SY; Bachmann M; Fritzsche S; Gallo-Ramirez LE; Reichl U
Appl Microbiol Biotechnol; 2016 Aug; 100(16):7181-92. PubMed ID: 27129532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
